AXGN
Axogen Inc
NASDAQ · Health Care
$34.93
+1.03 (+3.04%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 212.16M | 186.57M | 989.64M | 948.34M | 1.09B |
| Net Income | -11,282,527 | -8,929,189 | 100.83M | 77.32M | 101.42M |
| EPS | — | — | — | — | — |
| Profit Margin | -5.3% | -5.1% | 10.2% | 8.2% | 9.3% |
| Rev Growth | +13.7% | +13.7% | +8.4% | +5.7% | +24.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 274.78M | 274.78M | 180.09M | 208.98M | 163.48M |
| Total Equity | 600.61M | 600.61M | 1.21B | 1.19B | 1.27B |
| D/E Ratio | 0.46 | 0.46 | 0.15 | 0.18 | 0.13 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 3.38M | 2.82M | 132.63M | 143.45M | 157.61M |
| Free Cash Flow | — | — | 67.78M | 51.25M | 59.12M |